AARD insider filings

Aardvark Therapeutics, Inc. — 35 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-11-10. Screen AARD transaction legs live →

Insider transaction summary — last 90 days

2026-08-23 to 2026-11-21, from the filings listed below: 6 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By insider — same window

Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

InsiderFilingsPurchases (P)Sales (S)Other legs
Sun Nelson — See Remarks2—2 legs · 76,754 sh · $394,9576
Jaiman Manasi — Chief Medical Officer1——6
Lee Tien-Li — Chief Executive Officer, Director, 10% owner1——6
Zhang Zhongwei — Director2——1

Recent insider filings — Aardvark Therapeutics, Inc.

FiledFormInsiderReported transactionsSource
2026-11-104Lee Tien-Li — Chief Executive Officer, Director, 10% ownerGrant/award (A): 203,851 (derivative) · Disposition to issuer (D): 203,851 (derivative) · Grant/award (A): 549,534 (derivative) · Disposition to issuer (D): 549,534 (derivative) · Grant/award (A): 40,566 (derivative) · Disposition to issuer (D): 40,566 (derivative)EDGAR
2026-11-104Sun Nelson — See RemarksGrant/award (A): 70,549 (derivative) · Disposition to issuer (D): 70,549 (derivative) · Grant/award (A): 209,826 (derivative) · Disposition to issuer (D): 209,826 (derivative) · Grant/award (A): 23,719 (derivative) · Disposition to issuer (D): 23,719 (derivative)EDGAR
2026-11-104Jaiman Manasi — Chief Medical OfficerGrant/award (A): 70,549 (derivative) · Disposition to issuer (D): 70,549 (derivative) · Grant/award (A): 126,999 (derivative) · Disposition to issuer (D): 126,999 (derivative) · Grant/award (A): 177,012 (derivative) · Disposition to issuer (D): 177,012 (derivative)EDGAR
2026-10-084Zhang Zhongwei — DirectorGrant/award (A): 127,061 (derivative) @ $0EDGAR
2026-10-083Zhang Zhongwei — DirectorHoldings only — no transactions reportedEDGAR
2026-09-114Sun Nelson — See RemarksSale (S): 14,754 @ $5.00 · Sale (S): 62,000 @ $5.18EDGAR
2026-08-214Chi Jeffrey — DirectorGrant/award (A): 44,964 (derivative) @ $0EDGAR
2026-08-214Tong Victor Edward Jr — DirectorGrant/award (A): 44,964 (derivative) @ $0EDGAR
2026-08-214Baynes Roy D. — DirectorGrant/award (A): 44,964 (derivative) @ $0EDGAR
2026-08-214Graf Susan E — DirectorGrant/award (A): 44,964 (derivative) @ $0EDGAR
2026-02-114Sun Nelson — Chief Financial OfficerGrant/award (A): 70,549 (derivative) @ $0EDGAR
2026-02-114Lee Tien-Li — Chief Executive Officer, Director, 10% ownerGrant/award (A): 203,851 (derivative) @ $0EDGAR
2026-02-114Jaiman Manasi — Chief Medical OfficerGrant/award (A): 70,549 (derivative) @ $0EDGAR
2025-12-124Sun Nelson — Chief Financial OfficerPurchase (P): 3,000 @ $14.40EDGAR
2025-12-124Lee Tien-Li — Chief Executive Officer, Director, 10% ownerPurchase (P): 7,000 @ $14.48EDGAR
2025-10-164Lee Tien-Li — Chief Executive Officer, Director, 10% ownerOption exercise (M): 1,229 @ $4.24 · Option exercise (M): 1,229 (derivative) @ $0EDGAR
2025-10-164Jones Bryan — Chief Operating OfficerOption exercise (M): 1,250 @ $4.24 · Option exercise (M): 1,250 (derivative) @ $0EDGAR
2025-09-164Lee Tien-Li — Chief Executive Officer, Director, 10% ownerPurchase (P): 6,500 @ $9.51 · Purchase (P): 3,500 @ $9.94EDGAR
2025-09-124Lee Tien-Li — Chief Executive Officer, Director, 10% ownerPurchase (P): 9,000 @ $7.91 · Purchase (P): 6,000 @ $7.82 · Purchase (P): 5,000 @ $8.50EDGAR
2025-09-104Sun Nelson — Chief Financial OfficerPurchase (P): 6,000 @ $8.07EDGAR
2025-08-294Lee Tien-Li — Chief Executive Officer, Director, 10% ownerOption exercise (M): 17,209 @ $4.24 · Option exercise (M): 17,209 (derivative) @ $0EDGAR
2025-06-134Lee Tien-Li — Chief Executive Officer, Director, 10% ownerGrant/award (A): 549,534 (derivative) @ $0EDGAR
2025-06-134Chi Jeffrey — DirectorGrant/award (A): 61,017 (derivative) @ $0EDGAR
2025-06-134Jaiman Manasi — Chief Medical OfficerGrant/award (A): 126,999 (derivative) @ $0EDGAR
2025-06-134Sun Nelson — Chief Financial OfficerGrant/award (A): 209,826 (derivative) @ $0EDGAR
2025-06-134Tong Victor Edward Jr — DirectorGrant/award (A): 61,017 (derivative) @ $0EDGAR
2025-06-134Jones Bryan — Chief Operating OfficerGrant/award (A): 122,033 (derivative) @ $0EDGAR
2025-06-134Baynes Roy D. — DirectorGrant/award (A): 30,508 (derivative) @ $0EDGAR
2025-06-134Graf Susan E — DirectorGrant/award (A): 30,508 (derivative) @ $0EDGAR
2025-02-194Chi Jeffrey — DirectorConversion (C): 133,364 · Conversion (C): 1,130,135 (derivative) @ $0EDGAR
2025-02-194Vickers Venture Fund VI Pte Ltd — 10% ownerConversion (C): 1,637,411 · Conversion (C): 413,491 · Conversion (C): 13,875,429 (derivative) @ $0 · Conversion (C): 3,503,919 (derivative) @ $0EDGAR
2025-02-194Lee Tien-Li — Chief Executive Officer, Director, 10% ownerConversion (C): 41,303 · Purchase (P): 16,542 @ $16 · Conversion (C): 350,002 (derivative) @ $0EDGAR
2025-02-194Sun Nelson — Chief Financial OfficerConversion (C): 7,001 · Purchase (P): 10,000 @ $16 · Conversion (C): 59,332 (derivative) @ $0EDGAR
2025-02-194Cormorant Asset Management, LP
Chen Bihua
Conversion (C): 800,189 · Purchase (P): 187,500 @ $16 · Conversion (C): 6,780,810 (derivative)EDGAR
2025-02-194Decheng Capital Global Life Sciences Fund IV, L.P. — 10% owner
Decheng Capital Management IV (Cayman), LLC — 10% owner
Decheng Capital Global Healthcare Fund (Master), LP — 10% owner
Decheng Capital Global Healthcare GP, LLC — 10% owner
Cui Xiangmin — 10% owner
Conversion (C): 2,333,887 · Conversion (C): 333,412 · Purchase (P): 625,000 @ $16 · Purchase (P): 625,000 @ $16 · Conversion (C): 19,777,363 (derivative) @ $0 · Conversion (C): 2,825,337 (derivative) @ $0EDGAR

Recent 8-K events — Aardvark Therapeutics, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-138-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-10-238-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-10-228-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-10-088-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-178-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2026-08-118-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-128-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-148-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-078-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-248-K1.01 — Entry into a Material Definitive Agreement
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=AARD returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs